MedTrace Logo

Treatment and Prognosis of Neurogenic Orthostatic Hypotension : A Prospective Randomized Study

NCT02308124 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 87

Last updated 2021-10-19

Study results available
· View outcomes & findings →

Summary

Compare the effect of treatment of midodrine and pyridostigmine in neurogenic orthostatic hypotension and investigate the quality of life of treatment of neurogenic orthostatic hypotension.

Conditions

  • Orthostatic; Hypotension, Neurogenic

Interventions

DRUG

Midodrine

DRUG

Pyridostigmine Bromide

DRUG

Midodrine + pyridostigmine

Sponsors & Collaborators

  • Seoul National University Hospital

    lead OTHER

Principal Investigators

  • Kon Chu · Seoul National University Hospital, Seoul, South Korea

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-11-30
Primary Completion
2016-09-30
Completion
2016-09-30

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02308124 on ClinicalTrials.gov